Weidong Pan

5PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 08, 2025
Metabolic dysfunction-associated steatotic liver disease increases the incidence of metachronous liver metastases from TNM stage 0-II colorectal cancer.

Xiangjun Qian, Guojie Long, Qian Wang

|Nov 25, 2023
The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling.

Jiancong Xie, Taiwei Mo, Ruibing Li

|Feb 25, 2023
Construction and Validation of a Novel Prognosis Model in Colon Cancer Based on Cuproptosis-Related Long Non-Coding RNAs.

Guan-Zhan Liang, Xiao-Feng Wen, Yi-Wen Song

|Nov 26, 2022
A Novel m7G-Related Gene Signature Predicts the Prognosis of Colon Cancer.

Jing Chen, Yi-Wen Song, Guan-Zhan Liang

|Aug 26, 2022
The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients.

Xiangjun Qian, Yanna Liu, Fengping Wu

Pageof 1

Frequent Collaborators

3 joint publications

Zhenyu Xian

2 joint publications

Tuo Hu

1 joint publications

Xiangjun Qian

1 joint publications

Yuemin Nan